Sai Life Expands Bidar API Capacity to 700 KL
ECONOMY & POLICY

Sai Life Expands Bidar API Capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), a contract research, development, and manufacturing organisation (CRDMO) focused on pharmaceutical innovation, has announced the completion of Phase II of its new Production Block (PB-11) at its flagship API manufacturing facility in Bidar, Karnataka.
Phase I of PB-11, inaugurated in December 2024, added 110 kilolitres (KL) of capacity. With the addition of approximately 91 KL in Phase II during Q1 FY26, PB-11 now totals nearly 200 KL of reactor volume—making it the single largest production block at the site. This expansion increases Sai Life’s total installed reactor capacity at the Bidar facility to around 700 KL.

Commenting on the development, Krishna Kanumuri, CEO and Managing Director of Sai Life Sciences, stated, “This expansion is not just about capacity—it’s about scalability, reliability, and the ability to support clients as their needs evolve. We are enabling faster, more secure drug development by strengthening our commercial-scale API and intermediate manufacturing.”

PB-11 is a versatile block designed for the large-scale production of commercial products. Unit IV in Bidar serves as Sai Life’s core manufacturing hub, catering to highly regulated markets including the US, EU, and Japan.

Key features of the facility include:
  • 12 multipurpose production blocks totalling ~700 KL
  • Dedicated units for high-potency APIs (HPAPIs)
  • Advanced QC laboratories ensuring regulatory compliance
  • Capabilities such as lyophilisation, cryogenic and high-pressure reactions, and large-scale chromatography
The site has passed inspections by global regulatory bodies including the USFDA, Japan’s PMDA, and India’s CDSCO. As of March 2025, Sai Life’s manufacturing units had completed over 75 customer audits in the past three years—underscoring the company’s commitment to safety, quality, and regulatory excellence. 

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), a contract research, development, and manufacturing organisation (CRDMO) focused on pharmaceutical innovation, has announced the completion of Phase II of its new Production Block (PB-11) at its flagship API manufacturing facility in Bidar, Karnataka.Phase I of PB-11, inaugurated in December 2024, added 110 kilolitres (KL) of capacity. With the addition of approximately 91 KL in Phase II during Q1 FY26, PB-11 now totals nearly 200 KL of reactor volume—making it the single largest production block at the site. This expansion increases Sai Life’s total installed reactor capacity at the Bidar facility to around 700 KL.Commenting on the development, Krishna Kanumuri, CEO and Managing Director of Sai Life Sciences, stated, “This expansion is not just about capacity—it’s about scalability, reliability, and the ability to support clients as their needs evolve. We are enabling faster, more secure drug development by strengthening our commercial-scale API and intermediate manufacturing.”PB-11 is a versatile block designed for the large-scale production of commercial products. Unit IV in Bidar serves as Sai Life’s core manufacturing hub, catering to highly regulated markets including the US, EU, and Japan.Key features of the facility include:12 multipurpose production blocks totalling ~700 KLDedicated units for high-potency APIs (HPAPIs)Advanced QC laboratories ensuring regulatory complianceCapabilities such as lyophilisation, cryogenic and high-pressure reactions, and large-scale chromatographyThe site has passed inspections by global regulatory bodies including the USFDA, Japan’s PMDA, and India’s CDSCO. As of March 2025, Sai Life’s manufacturing units had completed over 75 customer audits in the past three years—underscoring the company’s commitment to safety, quality, and regulatory excellence. 

Next Story
Real Estate

LML Realty launches cinema campaign for industrial parks

LML Realty has launched a cinema advertising campaign with PVR INOX, showcasing its transition from the iconic scooter brand to an industrial infrastructure developer. The campaign will run across 81 screens in Gurugram and Faridabad.The campaign centres on a brand film tracing LML's journey since 1972, highlighting its evolution from manufacturing scooters to developing industrial infrastructure. The film also features the company's flagship LML Industrial Park at Jhirka Valley in Haryana, approved under the state's PADMA (Promoting Access and Development of MSME Advancement) scheme.The film ..

Next Story
Real Estate

Urja Senior Living unveils flagship Indore community

Urja Senior Living, a new initiative by CHL Living, will host the Grand Preview of its flagship senior living community in Indore on 8–9 August 2026, marking the group's entry into the senior housing segment.Located near Somanipuram on Khandwa Road Bypass, the development is designed to offer seniors an independent and community-oriented lifestyle, with residences, wellness-focused spaces and social engagement opportunities.The project reflects the growing demand for purpose-built senior living communities as more families seek housing solutions that combine independence, comfort and support..

Next Story
Infrastructure Transport

PVV Infra wins two highway amenity projects in Madhya Pradesh

PVV Infra has secured two contracts from National Highways Logistics Management Ltd (NHLML) to develop, operate and maintain Wayside Amenities (WSAs) on a design, build, operate and transfer (DBOT) basis in Madhya Pradesh.The projects are located on the NH-44 Gwalior–Jhansi corridor at Dabra and the NH-752D Ujjain–Garoth corridor at Dhanodiya. The annual lease rents are Rs 7.34 million and Rs 17.6 million, respectively.The facilities are intended to provide modern amenities for highway users while supporting the Government of India's programme to improve roadside infrastructure.The Dhanodi..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement